Antipsychotic Prescribing Pathways, Polypharmacy, and Clozapine Use in Treatment of Schizophrenia
Jessica L. Gören, Pharm.D.; Mark Meterko, Ph.D.; Sandra Williams, M.S.; Gary J. Young, J.D., Ph.D.; Errol Baker, Ph.D.; Chia-Hung Chou, Ph.D.; Amy M. Kilbourne, Ph.D., M.P.H.; Mark S. Bauer, M.D.
Psychiatric Services 2013;64:527-533.
doi:10.1176/appi.ps.002022012
Purchase Online access to this article for 24 hours
Clicking on the buy now link will redirect you to the shopping cart at APPI.org where you will be asked to log in or create an account to complete your transaction. Once your transaction is complete, you will receive an email with instructions for accessing this content online and in PDF format.
You may view, download, and/or print the article for your personal, scholarly, research, and educational use. You may not (i) distribute a copy
(electronic or otherwise) of the article without the written permission of APA, (ii) post the article on an electronic bulletin board or web
site, or (iii) charge for a copy (electronic or otherwise) of the article.